ISpecimen Debt to Equity Ratio 2020-2024 | ISPC

Current and historical debt to equity ratio values for ISpecimen (ISPC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ISpecimen debt/equity for the three months ending December 31, 2024 was 0.00.
ISpecimen Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $0.01B $0.00B 1.82
2024-09-30 $0.01B $0.01B 1.39
2024-06-30 $0.01B $0.01B 0.96
2024-03-31 $0.01B $0.01B 0.84
2023-12-31 $0.01B $0.01B 0.62
2023-09-30 $0.00B $0.01B 0.28
2023-06-30 $0.00B $0.02B 0.19
2023-03-31 $0.00B $0.02B 0.21
2022-12-31 $0.00B $0.02B 0.21
2022-09-30 $0.01B $0.02B 0.25
2022-06-30 $0.01B $0.03B 0.20
2022-03-31 $0.01B $0.03B 0.20
2021-12-31 $0.01B $0.03B 0.20
2021-09-30 $0.01B $0.01B 0.46
2021-06-30 $0.01B $0.01B 0.84
2021-03-31 $0.00B $0.00B 0.00
2020-12-31 $0.00B 0.00
2020-09-30 $0.00B $0.00B 0.00
2020-06-30 $0.00B $0.00B 0.00
2019-12-31 $0.02B $-0.01B -1.37
Sector Industry Market Cap Revenue
Medical Medical Services $0.003B $0.009B
iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $132.070B 24.77
Elevance Health (ELV) United States $84.109B 10.85
CVS Health (CVS) United States $76.951B 9.56
Cencora (COR) United States $56.664B 19.71
DiDi Global (DIDIY) China $22.591B 34.29
Natera (NTRA) United States $20.935B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.529B 0.00
Solventum (SOLV) United States $12.251B 12.97
CochLear (CHEOY) Australia $11.298B 0.00
Revvity (RVTY) United States $10.529B 18.12
ICON (ICLR) Ireland $10.336B 9.61
Viatris (VTRS) United States $9.730B 3.34
Doximity (DOCS) United States $9.525B 44.37
Avantor (AVTR) United States $8.647B 12.56
HealthEquity (HQY) United States $8.564B 42.13
Medpace Holdings (MEDP) United States $8.476B 22.51
Sonic Healthcare (SKHHY) Australia $8.176B 0.00
Charles River Laboratories (CRL) United States $6.716B 13.16
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.048B 37.47
Bausch + Lomb (BLCO) Canada $3.990B 23.52
Sotera Health (SHC) United States $3.452B 19.61
Surgery Partners (SGRY) United States $2.922B 38.00
Alignment Healthcare (ALHC) United States $2.865B 0.00
Concentras Parent (CON) United States $2.710B 15.66
Organon (OGN) United States $2.259B 2.40
Ardent Health Partners (ARDT) United States $2.091B 8.91
GeneDx Holdings (WGS) United States $2.043B 78.68
Premier (PINC) United States $1.899B 14.41
Progyny (PGNY) United States $1.759B 38.72
PACS (PACS) United States $1.497B 0.00
GoodRx Holdings (GDRX) United States $1.336B 26.71
Teladoc Health (TDOC) United States $1.195B 0.00
Pediatrix Medical (MD) United States $1.165B 8.86
Establishment Labs Holdings (ESTA) $1.059B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.944B 14.74
Agilon Health (AGL) United States $0.919B 0.00
Nutex Health (NUTX) United States $0.890B 13.45
AMN Healthcare Services Inc (AMN) United States $0.795B 7.44
QDM (QDMI) Hong Kong, SAR China $0.743B 0.00
Embecta (EMBC) United States $0.626B 4.22
InnovAge Holding (INNV) United States $0.531B 0.00
LifeMD (LFMD) United States $0.524B 0.00
Enhabit (EHAB) United States $0.518B 42.58
Auna S.A (AUNA) Luxembourg $0.492B 11.08
SBC Medicals (SBC) United States $0.471B 0.00
Sonida Senior Living (SNDA) United States $0.462B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.405B 0.00
Oncology Institute (TOI) United States $0.228B 0.00
Performant Healthcare (PHLT) United States $0.215B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.137B 22.33
OncoCyte (OCX) United States $0.096B 0.00
So-Young (SY) China $0.087B 0.00
Sera Prognostics (SERA) United States $0.066B 0.00
Ascend Wellness Holdings (AAWH) United States $0.061B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Biodesix (BDSX) United States $0.050B 0.00
Pheton Holdings (PTHL) China $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Basel Medical Group (BMGL) Singapore $0.025B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00